share_log

DEF 14A: Definitive information statements

DEF 14A: Definitive information statements

DEF 14A：股东委托书决议
美股sec公告 ·  05/30 14:18
Moomoo AI 已提取核心信息
60 Degrees Pharmaceuticals, Inc. (60P) has announced a series of significant corporate events, including the approval of a reverse stock split, amendments to equity incentive plans, and the ratification of RBSM LLP as their independent auditor for the fiscal year ending December 31, 2024. The reverse stock split, at a ratio ranging from 1:5 to 1:12, is intended to raise the per-share trading price of 60P's common stock to comply with Nasdaq listing requirements. Additionally, the company seeks shareholder approval to increase the number of shares authorized under its 2022 Equity Incentive Plan by 5,000,000 shares. Amendments to the strike price and vesting provisions of options granted to the CEO and CFO, as well as the issuance of options to a consultant, are also subject to shareholder...Show More
60 Degrees Pharmaceuticals, Inc. (60P) has announced a series of significant corporate events, including the approval of a reverse stock split, amendments to equity incentive plans, and the ratification of RBSM LLP as their independent auditor for the fiscal year ending December 31, 2024. The reverse stock split, at a ratio ranging from 1:5 to 1:12, is intended to raise the per-share trading price of 60P's common stock to comply with Nasdaq listing requirements. Additionally, the company seeks shareholder approval to increase the number of shares authorized under its 2022 Equity Incentive Plan by 5,000,000 shares. Amendments to the strike price and vesting provisions of options granted to the CEO and CFO, as well as the issuance of options to a consultant, are also subject to shareholder approval to comply with Nasdaq Listing Rule 5635(c). The company's board has the discretion to determine the timing and ratio of the reverse stock split and may abandon the plan before it becomes effective. The annual meeting of stockholders, where these proposals will be considered, is scheduled for July 16, 2024, and will be held virtually via audio webcast.
60 Degrees Pharmicals, Inc.（60P）宣布了一系列重大公司活动，包括批准反向股票拆分、修订股权激励计划以及批准RBSM LLP作为截至2024年12月31日的财年的独立审计师。反向股票拆分的比率从 1:5 到 1:12 不等，旨在提高60便士普通股的每股交易价格，以符合纳斯达克的上市要求。此外，该公司寻求股东批准，将其2022年股权激励计划授权的股票数量增加5,000,000股。对授予首席执行官和首席财务官的期权的行使价和归属条款的修订，以及向顾问发行期权，也需要获得股东批准，以遵守纳斯达克上市规则5635（c）。公司董事会有权决定反向股票拆分的时间和比例，并可能在计划生效之前放弃该计划。年度股东大会定于2024年7月16日举行，将通过网络音频直播虚拟举行，届时将审议这些提案。
60 Degrees Pharmicals, Inc.（60P）宣布了一系列重大公司活动，包括批准反向股票拆分、修订股权激励计划以及批准RBSM LLP作为截至2024年12月31日的财年的独立审计师。反向股票拆分的比率从 1:5 到 1:12 不等，旨在提高60便士普通股的每股交易价格，以符合纳斯达克的上市要求。此外，该公司寻求股东批准，将其2022年股权激励计划授权的股票数量增加5,000,000股。对授予首席执行官和首席财务官的期权的行使价和归属条款的修订，以及向顾问发行期权，也需要获得股东批准，以遵守纳斯达克上市规则5635（c）。公司董事会有权决定反向股票拆分的时间和比例，并可能在计划生效之前放弃该计划。年度股东大会定于2024年7月16日举行，将通过网络音频直播虚拟举行，届时将审议这些提案。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息